Loading
Every dated change on the records linked to Ependymoma, newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.
Maximal safe resection, second-look surgery for residual disease, then conformal or proton radiotherapy to the tumour bed (ACNS0121 approach); craniospinal irradiation only for disseminated disease.
Five-year event-free survival 68.
COG phase 2 (JCO 2019) reports outcomes by extent of resection and molecular group.